Device Trial Radar · NCT06970899
Initial Feasibility Study of the CycloPE® Device
Last checked: Nov 19, 2026Latest source record: May 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
15
Actual
Start
Jun 11, 2024
Primary completion
Apr 26, 2025
Study completion May 15, 2025
Sponsor
- Lead sponsor
- PATH EX, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- May 14, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a single-center, prospective, single-arm clinical study to evaluate the feasibility, safety, and performance of the PATH EX CycloPE® device on suspected bacteremia-associated sepsis. All participants are adults diagnosed with suspected bacteremia-associated sepsis, admitted to the intensive care unit (ICU), and meet the inclusion criteria.
Conditions
- Sepsis
- Infection
- Bacteremia Sepsis
- Systemic Inflammatory Response Syndrome (SIRS)
Interventions
PATH EX CycloPE® DeviceDevice
Participants in this arm will receive two extracorporeal blood filtration treatments using the PATH EX CycloPE® device. The first treatment will be initiated following baseline assessments, and the second treatment will occur 24-36 hours after the start of the first treatment. Each treatment will last up to 4 hours. The device is designed to target and remove bacteria from the bloodstream. All participants will also receive standard-of-care treatment for sepsis, including IV antibiotics, as determined by the treating physician.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Serious Adverse Events (SAEs) related to the investigational deviceTime frame: 7 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Erebuni Medical Cener
Yerevan, Armenia, Armenia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.